INVO Bioscience Inc (INVO)
0.8575
-0.01
(-1.32%)
USD |
NASDAQ |
Jun 28, 16:00
0.8575
0.00 (0.00%)
After-Hours: 20:00
INVO Bioscience Research and Development Expense (TTM): 0.0973M for March 31, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | 0.0973M |
| December 31, 2023 | 0.1659M |
| September 30, 2023 | 0.2339M |
| June 30, 2023 | 0.4065M |
| March 31, 2023 | 0.5134M |
| December 31, 2022 | 0.544M |
| September 30, 2022 | 0.534M |
| June 30, 2022 | 0.4141M |
| March 31, 2022 | 0.2543M |
| December 31, 2021 | 0.2164M |
| September 30, 2021 | 0.3736M |
| June 30, 2021 | 0.4308M |
| March 31, 2021 | 0.4346M |
| December 31, 2020 | 0.3984M |
| September 30, 2020 | 0.1775M |
| June 30, 2020 | 0.0649M |
| March 31, 2020 | 0.0301M |
| December 31, 2019 | 0.00 |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | |
| September 30, 2018 |
| Date | Value |
|---|---|
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2011 | |
| September 30, 2011 | 0.00 |
| June 30, 2011 | 0.00 |
| March 31, 2011 | 0.00 |
| December 31, 2010 | 0.00 |
| September 30, 2010 | 0.0027M |
| June 30, 2010 | 0.0027M |
| March 31, 2010 | 0.0027M |
| December 31, 2009 | 0.0077M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
Dec 2019
0.544M
Maximum
Dec 2022
0.2939M
Average
0.314M
Median
Research and Development Expense (TTM) Benchmarks
| Abbott Laboratories | 2.771B |
| Perspective Therapeutics Inc | 24.91M |
| Xtant Medical Holdings Inc | 1.689M |
| Asensus Surgical Inc | 34.98M |
| Catheter Precision Inc | 0.272M |